Novo Nordisk
NVO
NVO
643 hedge funds and large institutions have $9.5B invested in Novo Nordisk in 2020 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 164 increasing their positions, 281 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4% less capital invested
Capital invested by funds: $9.9B → $9.5B (-$397M)
1.41% less ownership
Funds ownership: 18.37% → 16.96% (-1.4%)
42% less repeat investments, than reductions
Existing positions increased: 164 | Existing positions reduced: 281
Holders
643
Holding in Top 10
21
Calls
$30.8M
Puts
$26.1M
Top Buyers
| 1 | +$98.9M | |
| 2 | +$29.4M | |
| 3 | +$21.5M | |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$17.5M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$16.9M |
Top Sellers
| 1 | -$321M | |
| 2 | -$136M | |
| 3 | -$62.2M | |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$57.2M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$55M |